News & Insights

Federal Circuit Severely Criticizes Patent Term Adjustment Rule

BREAKING: U.S. Supreme Court Says AIA Did Not Change Meaning of “On Sale” Bar

Pearl Cohen Secures New York Victory On Unread Terms of Use

NOW OPEN: Directors and Senior Executives Course

Federal Judge Chastises Attorneys for “Child”-ish Behavior

Pearl Cohen Team Secures Major Litigation Victory for Tech Client

A Guide to Directors During a Crisis in the Markets

Ninth Circuit Orders Payment of Nearly $2.5 Million in Post-License Damages

Stelexis Therapeutics Closes $43 million

CytoReason Signs Agreement with Pfizer

Gencore acquires Insight Biopharmaceuticals

Evidence of Improvement for Patentability